SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Leukosite (LKST)promising new biotech Cy? -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (15)12/18/1998 7:19:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 35
 
CNBC just announced that they would be discussing a new approach to asthma (targeting Interleukins) and this morning the WSJ has an extensive article on asthma programs targeting IL-4, IL-5, and IL-13.
I have started a thread at:
biocognizance.com
IMNX and AHP programs are mentioned



To: scaram(o)uche who wrote (15)1/1/1999 1:04:00 PM
From: Jim K.  Read Replies (1) | Respond to of 35
 
Hello to All:
I just opened new thread for the Joint Venture company ILXO.
techstocks.com

Web Site: ilexoncology.com

I think 1999 is going to be THE YEAR for these companies.
Maybe we should combine the threads. This new approach to treating Cancer is going to be the answer IMO.

Jim K.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News